Ongoing health challenges, including a 2022 stroke, 2023 depression treatment, and a November 2025 ventricular fibrillation episode requiring hospitalization, combined with reports of staff concerns and recent chief of staff turnover, have fueled speculation that Senator John Fetterman could depart before his term ends in 2029. Political isolation within the Democratic caucus, driven by his independent voting record on issues like Israel policy and Trump administration confirmations, adds pressure through primary chatter and party distancing. Counterbalancing these factors are Fetterman’s repeated public statements affirming his fitness to serve, commitment to remaining a Democrat, and continued legislative activity into 2026. This mix of verifiable medical history, institutional tensions, and personal resolve produces the near-even trader consensus on whether he stays through December 2026.
Ringkasan eksperimental yang dihasilkan AI dengan referensi data Polymarket. Ini bukan saran trading dan tidak berperan dalam bagaimana pasar ini diselesaikan. · DiperbaruiBARU
BARU
Dec 31, 2026
BARU
BARU
Dec 31, 2026
This market will resolve to “Yes” if John Fetterman ceases to be U.S. Senator from Pennsylvania for any period of time between market creation and the specified date (ET). Otherwise, this market will resolve to “No”.
An announcement of John Fetterman's resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from John Fetterman and the U.S. government; however, a consensus of credible reporting may also be used.Ongoing health challenges, including a 2022 stroke, 2023 depression treatment, and a November 2025 ventricular fibrillation episode requiring hospitalization, combined with reports of staff concerns and recent chief of staff turnover, have fueled speculation that Senator John Fetterman could depart before his term ends in 2029. Political isolation within the Democratic caucus, driven by his independent voting record on issues like Israel policy and Trump administration confirmations, adds pressure through primary chatter and party distancing. Counterbalancing these factors are Fetterman’s repeated public statements affirming his fitness to serve, commitment to remaining a Democrat, and continued legislative activity into 2026. This mix of verifiable medical history, institutional tensions, and personal resolve produces the near-even trader consensus on whether he stays through December 2026.
This market will resolve to “Yes” if John Fetterman ceases to be U.S. Senator from Pennsylvania for any period of time between market creation and the specified date (ET). Otherwise, this market will resolve to “No”.
An announcement of John Fetterman's resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from John Fetterman and the U.S. government; however, a consensus of credible reporting may also be used.
An announcement of John Fetterman's resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from John Fetterman and the U.S. government; however, a consensus of credible reporting may also be used.
Pasar Dibuka: Nov 14, 2025, 7:17 PM ET
Volume
$795Tanggal Berakhir
Dec 31, 2026Pasar Dibuka
Nov 14, 2025, 7:17 PM ETResolver
0x65070BE91...This market will resolve to “Yes” if John Fetterman ceases to be U.S. Senator from Pennsylvania for any period of time between market creation and the specified date (ET). Otherwise, this market will resolve to “No”.
An announcement of John Fetterman's resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from John Fetterman and the U.S. government; however, a consensus of credible reporting may also be used.Ongoing health challenges, including a 2022 stroke, 2023 depression treatment, and a November 2025 ventricular fibrillation episode requiring hospitalization, combined with reports of staff concerns and recent chief of staff turnover, have fueled speculation that Senator John Fetterman could depart before his term ends in 2029. Political isolation within the Democratic caucus, driven by his independent voting record on issues like Israel policy and Trump administration confirmations, adds pressure through primary chatter and party distancing. Counterbalancing these factors are Fetterman’s repeated public statements affirming his fitness to serve, commitment to remaining a Democrat, and continued legislative activity into 2026. This mix of verifiable medical history, institutional tensions, and personal resolve produces the near-even trader consensus on whether he stays through December 2026.
This market will resolve to “Yes” if John Fetterman ceases to be U.S. Senator from Pennsylvania for any period of time between market creation and the specified date (ET). Otherwise, this market will resolve to “No”.
An announcement of John Fetterman's resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from John Fetterman and the U.S. government; however, a consensus of credible reporting may also be used.
An announcement of John Fetterman's resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from John Fetterman and the U.S. government; however, a consensus of credible reporting may also be used.
Volume
$795Tanggal Berakhir
Dec 31, 2026Pasar Dibuka
Nov 14, 2025, 7:17 PM ETResolver
0x65070BE91...Ongoing health challenges, including a 2022 stroke, 2023 depression treatment, and a November 2025 ventricular fibrillation episode requiring hospitalization, combined with reports of staff concerns and recent chief of staff turnover, have fueled speculation that Senator John Fetterman could depart before his term ends in 2029. Political isolation within the Democratic caucus, driven by his independent voting record on issues like Israel policy and Trump administration confirmations, adds pressure through primary chatter and party distancing. Counterbalancing these factors are Fetterman’s repeated public statements affirming his fitness to serve, commitment to remaining a Democrat, and continued legislative activity into 2026. This mix of verifiable medical history, institutional tensions, and personal resolve produces the near-even trader consensus on whether he stays through December 2026.
Ringkasan eksperimental yang dihasilkan AI dengan referensi data Polymarket. Ini bukan saran trading dan tidak berperan dalam bagaimana pasar ini diselesaikan. · Diperbarui
Hati-hati dengan link eksternal.
Hati-hati dengan link eksternal.
Pertanyaan yang Sering Diajukan